can i switch from tirzepatide to semaglutide for weight loss Switching dosage chart: complete conversion guide Switching from Semaglutide to Tirzepatide:

Gastrointestinal symptoms particularly nausea, vomiting, diarrhoea, and constipationare common, with frequencies varying by product and dose (ranging from 10-40% in clinical trials according to SmPCs)

MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation

Improved Metabolic Health: Anecdotal evidence suggests that even small doses can boost metabolism, supporting gradual weight loss and better energy

Additionally, gastrointestinal side effects including nausea, vomiting, and reduced fluid intake can lead to dehydration , which may precipitate acute kidney injury (AKI), particularly in vulnerable individuals

2eh and Supplementary Fig

Biomed J Sci&Tech Res 7(2)-2018